Updated Date: Tue, 06 Aug 2024 00:00:00 EDT
Vous n'êtes pas connecté
- English
- Français
- عربي
- Español
- Deutsch
- Português
- русский язык
- Català
- Italiano
- Nederlands, Vlaams
- Norsk
- فارسی
- বাংলা
- اردو
- Azərbaycan dili
- Bahasa Indonesia
- Հայերեն
- Ελληνικά
- Bosanski jezik
- українська мова
- Íslenska
- Türkmen, Түркмен
- Türkçe
- Shqip
- Eesti keel
- magyar
- Қазақ тілі
- Kalaallisut ; kalaallit oqaasii
- Lietuvių kalba
- Latviešu valoda
- македонски јазик
- Монгол
- Bahasa Melayu ; بهاس ملايو
- ဗမာစာ
- Slovenščina
- тоҷикӣ ; toğikī ; تاجیکی
- ไทย
- O'zbek ; Ўзбек ; أۇزبېك
- Tiếng Việt
- ភាសាខ្មែរ
- རྫོང་ཁ
- Soomaaliga ; af Soomaali
Maroc - MOUNTAINTODAY.IN - A La Une - 09/Jul 18:52
Melanoma Pipeline 2024 | IO Biotech, Moderna Inc., Merck Sharp & Dohme LLC, BioNTech SE, TILT Biotherapeutics LLC, Nykode Therapeutics, Achilles Therapeutics UK Limited, Evaxion Biotech, InxMed
DelveInsight’s, “Melanoma Pipeline Insight 2024” report provides comprehensive insights about 150+ companies and 170+ pipeline drugs in Melanoma pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also
Articles similaires
KEYTRUDA (pembrolizumab) injection, powder, lyophilized, for solution KEYTRUDA (pembrolizumab) injection, solution [Merck Sharp & Dohme LLC ]
nlm.nih.gov - 16/Aug 04:00
Updated Date: Fri, 16 Aug 2024 00:00:00 EDT
Adenoid Cystic Carcinoma Market to Grow at a Substantial Growth Rate During the Forecast Period | HLB, Ayala Pharma, Merck, Amgen, CureVac, Actuate Therapeutics
mountaintoday.in - 15/Aug 17:40
Adenoid Cystic Carcinoma Market According to DelveInsight, the dynamics of the Adenoid Cystic Carcinoma market are expected to evolve in the coming...
Positive Phase 2a Fibromyalgia Results Deliver Pain Reduction in 100% of Patients, Strengthening IP Position and Clinical Trial Strategy
entrepreneur.ca - 13/Aug 03:04
Positive Phase 2a Fibromyalgia Results Deliver Pain Reduction in 100% of Patients, Strengthening IP Position and Clinical Trial Strategy Tryptamine...
Will Ionis' (IONS) Wholly-Owned Drugs Drive Future Growth?
zacks.com - 15/Aug 13:15
Ionis (IONS) enjoys a diverse revenue stream, including numerous sources of collaborative and R&D revenues. These funds enable it to invest in the...
Epstein Barr Virus Market is Expected to Show a Remarkable Growth During the Forecast Period | Viracta, Atara Biotherapeutics, AlloVir
mountaintoday.in - 15/Aug 17:32
Epstein Barr Virus (EBV) Market In 2021, the Epstein-Barr Virus market across the seven major markets was valued at approximately USD 1.5 billion....
Beam Therapeutics (BEAM) Q2 Earnings Beat, Revenues Miss
zacks.com - 07/Aug 14:50
Beam Therapeutics (BEAM) reports mixed second-quarter results. The company remains focused on pipeline development.
OPFOLDA (miglustat) capsule [AMICUS THERAPEUTICS US, LLC]
nlm.nih.gov - 08/Aug 04:00
Updated Date: Thu, 08 Aug 2024 00:00:00 EDT
Les derniers communiqués
-
Aucun élément